Can exercise be safe for FMD patients? new survey seeks answers
NCT ID NCT07529691
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is a large national survey of 2,000 people with fibromuscular dysplasia (FMD), a rare artery disease that can cause strokes or heart attacks. Researchers want to understand what physical activity restrictions doctors recommend and how those restrictions affect patients' quality of life and emotional well-being. The goal is to gather information that could lead to better, more consistent activity guidelines for FMD patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this survey could provide the first evidence to guide safe physical activity recommendations for people with FMD, potentially improving their quality of life.
- What could go wrong
- This is an observational survey, not a treatment trial. It will gather opinions and self-reported data, which may not reflect objective medical outcomes or lead directly to new guidelines.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 2,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2026
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Individuals with a diagnosis of fibromuscular dysplasia
- Ages
-
18 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * Participants with a diagnosis of fibromuscular dysplasia * Age range = 18-100 years Exclusion Criteria: * Subjects who have an inability to complete the electronic consent form or electronic survey for any reason * Subjects who are non-English speaking who cannot read the electronic consent form or electronic survey
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fibromuscular dysplasia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could intense workouts be safe after a rare heart attack? a trial puts HIIT to the test
- Could a hidden artery condition explain heart attacks in young women?
- Mayo clinic investigates Nerve-Artery link in rare heart condition SCAD
- Can a home exercise program help women heal after a rare heart attack?
- Global SCAD registry launches to prevent recurrence of rare heart attacks
- Can exercise be safe after a heart artery tear? new study aims to find out.